Funding
Current Grant Awards
05/01/2025 – 04/30/2026 PI: Vatsalya Vatsalya
- Funding Agency: Altimmune Corporation
- Title: ALT-801-241 ALD Study
- Role: Principal Investigator.
- Capacity effort: 2%.
10/01/2024 – 09/30/2031 PIs: Craig McClain, Ashwani Singal
- Funding Agency: NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM
- Title: Integrated therapies for alcohol use and ALD (ITAALD) Network – UofL Clinical Center
- Role: Site Clinical Director.
- Capacity effort: 5%.
08/15/2024 – 08/14/2026 CREATE. PI-Mentee: Aishwarya Thakurdesai. Mentor: Vatsalya Vatsalya
- Funding Agency: Department of Medicine, University of Louisville
- Title: Pilot open-label evaluation of varenicline tartrate as dual-target therapy for Alcohol Use Disorder and comorbid Alcohol-associated Liver Disease
- Role: Primary Mentor.
- Capacity effort: 2%. Competitive/Awarded
09/01/2024 – 04/30/2025 INBRE Supplement. Vatsalya Vatsalya (M-PI with Bert Watson).
- Funding Agency: NIH (INBRE).
- Title: Novel personalized medicine treatment/biomarkers for AUD/ALD.
- Role: M-PI.
- Capacity effort: 3%. Competitive/Awarded.
04/01/2024 – 03/31/2026 Medicaid. PI: Maiying Kong
- Funding Agency: Medicaid.
- Title: Treatment development of AUD.
- Role: Clinical Investigator (Lead - AUD section).
- Capacity effort: 3%. Competitive/Awarded.
10/01/2022-09/30/2025 Excellence Research Recruitment Program. PI: Vatsalya Vatsalya
- Funding Agency: Jewish Heritage Foundation
- Title: Establishment of research program
- Role: Principal Investigator (PI).
- Capacity effort: 2%. Competitive/Awarded.
2021/05/01 – 2027/04/30 K23 AA029198. PI: Vatsalya Vatsalya
- Funding Agency: NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM
- Title: Lactobacillus Rhamnosus: A Novel Probiotic Therapy for Treating Alcohol Use Disorder
- Capacity effort: 75%. Competitive/Awarded.
Current Contract Project
2017/04/01 – 2027/03/31 NCIG-003: PD: Raye Litten
- Contract Agency: NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM
- Title: Varenicline for Alcohol Dependence (Intra-and Extramural). NCIG-003/ Umbrella Grant: NCT01146613
- Project: Repurposing Assessment of Varenicline in Lowering Alcohol Consumption
- Role: Project Principal Investigator (PI)
- Capacity effort: 2%. Non-competitive/Awarded
2024/11/01 – 2029/10/01 PDs: Melanie Schwandt and Vatsalya Vatsalya
- Contract Agency: NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM
- Title: Biomarkers of CSF Characterize the Clinical Domains of Alcohol Use Disorder via the Mechanism of Gut-Brain Axis
- Role: Site Principal Investigator (PI)
- Capacity effort: 2%. Non-competitive/Awarded